Study on the relative bioavailability of captopril tablets in volunteers
Zhang Shu-y
Abstract
Zhang Shu-y
Abstract
Objective To study the relative bioavailability of captopril tablets in human being.Methods The randomized,crossed-over study was conducted in 18 healthy volunteers.After a single dose(containing 100 mg captopril),the plasma drug levels were determined by RP-HPLC.Results The main pharmacokinetic parameters of captopril in the test and reference formulation were as follows: tmax were( 0.83±0.23) and(0.81±0.28) h;cmax were(22.88±13.64) and(20.96±8.06) mg·L-1,t1/2were(1.95±0.11)and(1.89±0.11) h;AUC0→∝were(66.92±11.15) and(67.85±12.33) mg·h·L-1,respectively.Conclusion It can be showed that the two formulations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the relative bioavailability of captopril tablets in human being.Methods The randomized,crossed-over study was conducted in 18 healthy volunteers.After a single dose(containing 100 mg captopril),the plasma drug levels were determined by RP-HPLC.Results The main pharmacokinetic parameters of captopril in the test and reference formulation were as follows: tmax were( 0.83±0.23) and(0.81±0.28) h;cmax were(22.88±13.64) and(20.96±8.06) mg·L-1,t1/2were(1.95±0.11)and(1.89±0.11) h;AUC0→∝were(66.92±11.15) and(67.85±12.33) mg·h·L-1,respectively.Conclusion It can be showed that the two formulations are bioequivalent.
Key concepts: Captopril, Bioavailability, Bioequivalence, Cmax, Pharmacokinetics, Pharmacology, Pharmaceutics, Chemistry